跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REANEU FOCUSPRIMX TABLET - NPRA Drug Approval Details
Approvals
/
NPRA
/
REANEU FOCUSPRIMX TABLET
Approved
STANDARD
REANEU FOCUSPRIMX TABLET
Sky Nutraceuticals Sdn. Bhd.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Mar 26, 2026
Approval ID
4fc3ca157cd3729c
Company
Sky Nutraceuticals Sdn. Bhd.
Type
Standard
Approval Details
Approval Id
4fc3ca157cd3729c
Drug Approval Npra Name
REANEU FOCUSPRIMX TABLET
Product Name
REANEU FOCUSPRIMX TABLET
Registration Number
MAL26036106N
Holder Company Name
Sky Nutraceuticals Sdn. Bhd.
Holder Address
LOT 4397 (PT 379), JALAN PERINDUSTRIAN BUKIT MINYAK 7, KAWASAN PERINDUSTRIAN BUKIT MINYAK, 14100 BUKIT MERTAJAM MALAYSIA
Holder Phone
045015188
Manufacturer Company Name
Sky Nutraceuticals Sdn. Bhd.
Manufacturer Address
LOT 4397 (PT 379), JALAN PERINDUSTRIAN BUKIT MINYAK 7 KAWASAN PERINDUSTRIAN BUKIT MINYAK 14100 BUKIT MERTAJAM MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL26036106N
Version
1774552219
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Mar 26, 2026
Approval ID
4fc3ca157cd3729c
Type
Standard
Source
Official Source
Back to NPRA Approvals